IP Library › Granted Patent US 7,524,497
Granted Patent B2
US 7,524,497 · App. 11/290,153 · Granted Apr 28, 2009

Antibodies to PRO 1120 polypeptide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,524,497
App. No.
11/290,153
Granted
Apr 28, 2009
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (7)

1. An isolated antibody that specifically binds to (a) the polypeptide shown in SEQ ID NO:20, (b) the polypeptide shown in SEQ ID NO:20, lacking its associated signal peptide, (c) a polypeptide encoded by the cDNA deposited under ATCC Accession Number 203040, or (d) the polypeptide of (c), lacking its associated signal peptide.

2. The antibody of claim 1 which is a monoclonal antibody.

3. The antibody of claim 1 which is a humanized antibody.

4. The antibody of claim 1 which is an antibody fragment.

5. The antibody of claim 1 which is labeled.

6. The antibody of claim 1 which is conjugated to a cytotoxic or growth inhibitory agent.

7. The antibody of claim 1 which is a human antibody.